Translational Neuroendocrinology
1 – 50 of 126
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage
2024) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 37(1). p.100382-100382(
- Contribution to journal › Article
-
Mark
Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
-
Mark
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease
(
- Contribution to journal › Article
- 2022
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model
(
- Contribution to journal › Article
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington's disease mouse models
(
- Contribution to journal › Article
-
Mark
Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
(
- Contribution to journal › Scientific review
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2021
-
Mark
Early white matter pathology in the fornix of the limbic system in Huntington disease
(
- Contribution to journal › Article
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
-
Mark
Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model
(
- Contribution to journal › Article
-
Mark
Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma
(
- Contribution to journal › Article
-
Mark
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease
(
- Contribution to journal › Article
-
Mark
Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död
(
- Contribution to journal › Article
- 2019
-
Mark
SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease
(
- Contribution to journal › Article
-
Mark
Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity
(
- Contribution to journal › Article
-
Mark
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease
(
- Contribution to journal › Scientific review
-
Mark
Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis
(
- Contribution to journal › Article
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
The psychopharmacology of Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism
(
- Contribution to journal › Scientific review
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation
(
- Contribution to journal › Article
-
Mark
Thermoregulatory disorders in Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Thermoregulation in amyotrophic lateral sclerosis
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Laminin α1 reduces muscular dystrophy in dy2Jmice
(
- Contribution to journal › Article
-
Mark
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay
(
- Contribution to journal › Article
-
Mark
Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma
(
- Contribution to journal › Article
- 2017
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Ethical aspects of a predictive test for Huntington's Disease: A long term perspective.
(
- Contribution to journal › Article
-
Mark
Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Hypothalamic and Metabolic Dysfunction in Genetic Models of Huntington’s Disease
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
Subjective sleep problems in Huntington's disease : A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function
(
- Contribution to journal › Article
-
Mark
Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Hypothalamic dysfunction revealed by magnetic resonance diffusion tensor imaging in childhood leukemia survivors treated with cranial radiotherapy but not in craniopharyngeoma survivors
2016) Endokrindagarna(
- Contribution to conference › Poster
- 2015
-
Mark
Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.
(
- Contribution to journal › Article
-
Mark
Volumetric analysis of the hypothalamus in Huntington Disease using 3T MRI: the IMAGE-HD Study.
(
- Contribution to journal › Article
-
Mark
New perspectives on pathology in Huntington's disease - characterization of hypothalamic changes
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study.
(
- Contribution to journal › Letter
-
Mark
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
(
- Contribution to journal › Article
-
Mark
Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.
(
- Contribution to journal › Article